Sylvie Gazzéri
Centre National de la Recherche Scientifique · 134 works · 4,408 citations · h-index 39
Top works
- Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
- Immunohistochemical study of p53 in human lung carcinomas.
- Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma.
- Mechanisms of p16INK4A inactivation in non small-cell lung cancers
- E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors
- Alterations of expression of Rb, p16INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significance
- Human ARF binds E2F1 and inhibits its transcriptional activity
- The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer.
- Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer
- Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro‐endocrine lung carcinomas
- Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors
- p14 ARF Activates a Tip60-Dependent and p53-Independent ATM/ATR/CHK Pathway in Response to Genotoxic Stress
- Mechanism of Retinoblastoma Gene Inactivation in the Spectrum of Neuroendocrine Lung Tumors
- Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma
- p53 genetic abnormalities and myc activation in human lung carcinoma
- p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
- Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
- p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice
- No evidence of somatic FGFR3 mutation in various types of carcinoma
- The ARF tumor suppressor: Structure, functions and status in cancer